Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
POST-ETERNAL: Tenecteplase for Basilar Artery Occlusion Stroke
NCT05105633Phase 3Recruiting
- Sponsor
- University of Melbourne
- Start
- Nov 2021
- Primary completion
- May 2028
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 3
01
Overview
A Phase 3 trial of tenecteplase in ischemic stroke, basilar artery occlusion (BAO), sponsored by University of Melbourne. Started Nov 2021; status: recruiting.
02
Drugs
tenecteplase
03
Conditions
ischemic strokebasilar artery occlusion (BAO)
Beyond the preview
Go deeper on NCT05105633.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05105633.